Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Additional Information (Details)

v3.21.4
Summary of Significant Accounting Policies - Additional Information (Details)
3 Months Ended 12 Months Ended
Oct. 22, 2021
USD ($)
$ / shares
shares
Apr. 22, 2021
$ / shares
shares
Nov. 30, 2021
USD ($)
plan
shares
Nov. 30, 2020
USD ($)
Aug. 31, 2020
segment
Oct. 19, 2021
shares
Aug. 31, 2021
USD ($)
shares
Dec. 31, 2020
Jan. 01, 2020
Concentration Risk [Line Items]                  
Contract with customer, term     12 months            
Contract with customer, cancellation period     30 days            
Unbilled accounts receivable     $ 2,700,000       $ 2,741,000    
Number of reportable segments | segment         1        
Cash, uninsured amount     1,266,000            
Capitalized computer software, net     0       0    
Research and development expense     2,200,000 $ 1,400,000          
Capitalized computer software, additions     0 0          
Workers' compensation, claim responsibility per occurrence     500,000            
Workers' compensation asset, current     95,000       155,000    
Workers' compensation asset, noncurrent     246,000       386,000    
Workers' compensation liability, current     604,000       663,000    
Workers' compensation liability, noncurrent     1,321,000       $ 1,646,000    
Disposal group, including discontinued operation, workers' compensation asset, current     200,000            
Disposal group, including discontinued operation, workers' compensation liability, current     1,400,000            
Disposal group, including discontinued operation, workers' compensation asset, noncurrent     600,000            
Disposal group, including discontinued operation, workers' compensation liability, noncurrent     3,600,000            
Advertising expense     $ 401,000 202,000          
Number of stock-based compensation plans | plan     1            
Class of warrant or right, outstanding (in shares) | shares     17,491,772       9,592,085    
Temporary equity, carrying amount, attributable to parent     $ 116,725,000       $ 0    
Remeasurement of IHC temporary equity     13,270,000            
SPAC related offering costs paid     $ 3,502,000 $ 0          
IHC                  
Concentration Risk [Line Items]                  
Variable interest entity, qualitative or quantitative information, ownership percentage     15.00%            
Common stock, shares, owned (in shares) | shares     2,175,000            
Remeasurement of IHC temporary equity     $ 9,500,000            
SPAC related offering costs paid     $ 3,500,000            
IHC                  
Concentration Risk [Line Items]                  
Sale of stock, number of shares issued in transaction (in shares) | shares   2,000,000              
Sale of stock, price per share (in dollars per share) | $ / shares   $ 4.7472              
IPO | IHC                  
Concentration Risk [Line Items]                  
Sale of stock, number of shares issued in transaction (in shares) | shares     11,500,000            
Proceeds from initial public offering of IHC $ 115,000,000                
Assets held-in-trust $ 1,725,000   $ 1,675,000            
Sale of stock, price per share (in dollars per share) | $ / shares $ 10.00                
Sale of stock, number of common shares issued per unit (in shares) | shares 1         1      
Sale of stock, number of warrants issued per unit (in shares) | shares 1                
Class of warrant or right, number of securities called by each warrant or right (in shares) | shares 1         1      
Exercise price of warrants (in dollars per share) | $ / shares $ 11.50                
Business combination, initial business combination consummation period 12 months                
Redeemable noncontrolling interest, equity, common, redemption percentage 100.00%                
IPO | IHC | Placement Warrants                  
Concentration Risk [Line Items]                  
Exercise price of warrants (in dollars per share) | $ / shares $ 11.50                
Class of warrant or right, outstanding (in shares) | shares 4,639,102                
Sale of warrants, price per share (in dollars per share) | $ / shares $ 1.00                
Aggregate purchase price $ 4,639,102                
Measurement Input, Discount Rate                  
Concentration Risk [Line Items]                  
Note receivable, measurement input     0.15   0.15     0.15 0.10
Minimum                  
Concentration Risk [Line Items]                  
Capitalized software development, useful life     3 years            
Maximum                  
Concentration Risk [Line Items]                  
Capitalized software development, useful life     5 years            
Three Clients | Customer Concentration Risk | Accounts Receivable                  
Concentration Risk [Line Items]                  
Concentration risk, percentage     98.00%